Skip to main content
. 2018 Sep 5;50(9):118. doi: 10.1038/s12276-018-0135-9

Fig. 8. Proposed signaling mechanism for the anti-cancer effect of BJ-2302, a Src inhibitor, in MDA-MB-231 human TNBC cells.

Fig. 8

The anti-metastatic, anti-tumor effect of BJ-2302 was mediated by the down-regulation of CTSS and MMP-9 protein expression via suppression of Src-mediated dual activation of the PI3K/Akt and Ras/Raf/ERK pathways